(News) Mumbai overtakes Bangalore, emerges as top biotech city
Mumbai overtakes Bangalore, emerges as top biotech city
Mumbai outpaced Bangalore, with a margin of about Rs 200 crore, to become
India's top biotech city in terms of revenue while city-based bio
pharmaceuticals major Biocon clocked the highest revenue in 2009-10.
Biocon, known for its insulin and cancer drugs, topped the Biospectrum-ABLE list
of top 20 Biotech companies after a gap of four years growing at 29.34 per cent
to record revenues of Rs 1,180 crore, said the eighth annual survey.
The survey has been jointly conducted by the Association of Biotechnology Led
Enterprises (ABLE) and monthly journal BioSpectrum from the CyberMedia group
based on inputs from over 150 biotech companies.
According to the survey, the Indian biotech industry has grown three-folds in
just five years to report revenues of USD three billion in 2009-10, a growth of
17 per cent over the previous year.
The Biopharma sector contributed nearly three-fifth to industry's revenues at Rs
8,829 crore, a growth of 12 per cent followed by Bioservices at Rs 2,639 crore
and Bioagri at Rs 1,936 crore. The remaining revenue came from Bioindustrial
segment with a contribution of Rs 564 crore and Bioinformatics at Rs 231 crore.
The sector earns a little more than half of its revenue from exports. Biopharma
and Bioservices sector contributed 63 per cent and 33 per cent to the total
biotech exports, respectively. The Bioagriculture, Bioindustrial and
Bioinformatics sectors remained focused on domestic operations bringing in
nearly 90 per cent of their revenues from India.
The BioSpectrum study notes that the biotechnology ecosystem has become strong
with technology providers and the biotech education sectors playing a key role.
While Biocon was number one, Pune-based Serum Institute of India slipped to the
second spot with revenues of Rs 850 crore.
Panacea Biotec, Nuziveedu Seeds and Reliance Life Sciences were ranked number
three, four and five, respectively. The next five positions went to Quintiles,
Rasi Seeds, NovoNordisk, Shantha Biotech and Mahyco.
Western India continued to dominate India's biotech industry with 46 per cent
share in the overall revenues of Rs 14,199 crore.
Read more..
Courtesy:
Economictimes.indiatimes.com
- guru's blog
- Login to post comments